(Q44507323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

0 references

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

5

Patrick Marcellin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Chris Westland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

William Delaney

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Huiling Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Shan-Shan Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Stephanos Hadziyannis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

John Fry

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Carol Brosgart

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Craig Gibbs

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Michael Miller

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Shelly Xiong

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

107-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

Primate hepatitis B viruses - genetic diversity, geography and evolution

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Structural and functional heterogeneity of naturally occurring hepatitis B virus variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Clinical significance of hepatitis B virus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B genotypes and the response to interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Sequence and phylogenetic analysis of hepatitis B virus genotype G isolated in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900700-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0016-5085(03)00700-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12851876%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference